Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcadia Biosciences (RKDA) Assets Average (2016 - 2025)

Arcadia Biosciences filings provide 11 years of Assets Average readings, the most recent being $7.6 million for Q4 2025.

  • On a quarterly basis, Assets Average fell 47.39% to $7.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.6 million, a 47.39% decrease, with the full-year FY2025 number at $10.0 million, down 39.61% from a year prior.
  • Assets Average hit $7.6 million in Q4 2025 for Arcadia Biosciences, down from $8.2 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $70.8 million in Q2 2021 to a low of $7.6 million in Q4 2025.
  • Median Assets Average over the past 5 years was $26.9 million (2023), compared with a mean of $30.0 million.
  • Biggest five-year swings in Assets Average: soared 102.21% in 2021 and later crashed 49.79% in 2025.
  • Arcadia Biosciences' Assets Average stood at $51.6 million in 2021, then crashed by 38.54% to $31.7 million in 2022, then tumbled by 31.9% to $21.6 million in 2023, then crashed by 33.39% to $14.4 million in 2024, then plummeted by 47.39% to $7.6 million in 2025.
  • The last three reported values for Assets Average were $7.6 million (Q4 2025), $8.2 million (Q3 2025), and $10.4 million (Q2 2025) per Business Quant data.